Structure

InChI Key QWAXKHKRTORLEM-UGJKXSETSA-N
Smile CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1
InChI
InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C38H50N6O5
Molecular Weight 670.86
AlogP 3.09
Hydrogen Bond Acceptor 7.0
Hydrogen Bond Donor 5.0
Number of Rotational Bond 12.0
Polar Surface Area 166.75
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 49.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Human immunodeficiency virus type 1 protease inhibitor DailyMed

Metabolites

visNetwork

Indications

Mesh Heading Maximum Phase Mesh ID Reference
HIV Infections 4 D015658 ClinicalTrials
Acquired Immunodeficiency Syndrome 3 D000163 ClinicalTrials
AIDS-Associated Nephropathy 3 D016263 ClinicalTrials
Hypertension, Pulmonary 0 D006976 ClinicalTrials

Related Entries

MCS

Scaffolds

Salt

Side Effects from Label

Cross References

Resources Reference
CAS NUMBER 127779-20-8
ChEBI 63621
ChEMBL CHEMBL114
DrugBank DB01232
DrugCentral 2422
EPA CompTox DTXSID6044012
FDA SRS L3JE09KZ2F
Guide to Pharmacology 4813
KEGG D00429
PDB ROC
PubChem 441243
SureChEMBL SCHEMBL6881
ZINC ZINC000003914596